Efavirenz 600 mg Tab
Efavirenz 600 mg Tablets are a non-nucleoside reverse transcriptase inhibitor formulated for once-daily administration, playing an established role in combination antiretroviral regimens for the long-term management of HIV-1 infection under recommended treatment protocols.
Product Details
Therapeutic Class
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
600 mg once daily, preferably at bedtime, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets